ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies, an industry leader in investor relations, media, ...
Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...
While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...
2d
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On
This immuno-driven diagnostics company, known for partnerships with Genentech and Microsoft, just reported a notable insider ...
Innovation often pays off, and this biotech could cement its innovative capabilities in the next few years.
In February, a small biotech company reached a breakthrough with the FDA, agreeing to a clinical trial plan. The problem: The ...
The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...
Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted ...
One of the world’s largest biotech companies is closing its only office in the Bay Area. Pfizer is shutting down its office ...
The news is the latest example of the biotech industry's struggles in the Bay Area.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results